Anti-TNF-α immunotherapy is associated with increased gingival inflammation without clinical attachment loss in subjects with rheumatoid arthritis

Journal of Periodontology

Volumn 79, Issue 9, 2008, Pages 1645-1651

  Pers, Jacques Olivier ^a   Saraux, Alain ^b   Pierre, Roselyne ^a   Youinou, Pierre ^a,b  

^a UNIVERSITÉ DE BRETAGNE OCCIDENTALE   (France)

^b Medical and Dental School

Author keywords

Bone resorption; Immunotherapy; Periodontitis; Rheumatoid arthritis; Tumor necrosis factor alpha

Indexed keywords

ANTIRHEUMATIC AGENT; INFLIXIMAB; METHOTREXATE; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CROSS-SECTIONAL STUDY; DRUG ANTAGONISM; FEMALE; GINGIVA BLEEDING; GINGIVITIS; HUMAN; LONGITUDINAL STUDY; MALE; MICROBIOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; PERIODONTAL DISEASE; PERIODONTICS; PERIODONTITIS; RHEUMATOID ARTHRITIS; SMOKING; TOOTH PLAQUE;

ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CROSS-SECTIONAL STUDIES; DENTAL PLAQUE INDEX; FEMALE; GINGIVAL HEMORRHAGE; GINGIVITIS; HUMANS; LONGITUDINAL STUDIES; MALE; METHOTREXATE; MIDDLE AGED; PERIODONTAL ATTACHMENT LOSS; PERIODONTAL INDEX; PERIODONTAL POCKET; PERIODONTITIS; SMOKING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 51249097741     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2008.070616     Document Type: Article

References (17)

1. Williams RO, Feldmann M, Maini RN. Cartilage destruction and bone erosion in arthritis: The role of tumour necrosis factor alpha. Ann Rheum Dis 2000; 59(Suppl. 1):i75-i80.
2. Williams RC. Periodontal disease. N Engl J Med 1990; 322:373-382.
3. Greenwald RA, Kirkwood K. Adult periodontitis as a model for rheumatoid arthritis (with emphasis on treatment strategies). J Rheumatol 1999;26:1650-1653.
4. Nanes MS. Tumor necrosis factor-alpha: Molecular and cellular mechanisms in skeletal pathology. Gene 2003;321:1-15.
5. Maini RN, Breedveld FC, Kalden JR, et al. Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis. Arthritis Rheum 1998;41:1552-1563.
6. Lipsky PE, van der Heijde DM, St Clair EW, et al. Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. N Engl J Med 2000;343:1594-1602.
7. Assuma R, Oates T, Cochran D, Amar S, Graves DT. IL-1 and TNF antagonists inhibit the inflammatory response and bone loss in experimental periodontitis. J Immunol 1998;160:403-409.
8. Verzeletti GN, Gaio EJ, Rösing CK. Effect of methotrexate on alveolar bone loss in experimental periodontitis in Wistar rats. Acta Odontol Scand 2007;65:348-351.
9. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-324.
10. Ramfjord SP. The periodontal disease index (PDI). J Periodontol 1967;38:602-610.
11. Pers JO, d'Arbonneau F, Devauchelle-Pensec V, Saraux A, Pennec YL, Youinou P. Is periodontal disease mediated by salivary BAFF in Sjögren's syndrome? Arthritis Rheum 2005;52:2411-2414.
12. Kasser UR, Gleissner C, Dehne F, Michel A, Willershausen-Zönnchen B, Bolten WW. Risk for periodontal disease in patients with longstanding rheumatoid arthritis. Arthritis Rheum 1997;40:2248-2251.
13. Ribeiro J, Leao A, Novaes AB. Periodontal infection as a possible severity factor for rheumatoid arthritis. J Clin Periodontol 2005;32:412-416.
14. Mercado FB. Inter-relationships between rheumatoid arthritis and periodontal disease. A review. J Clin Periodontol 2003;30:761-772.
15. Curtis JR, Patkar N, Xie A, et al. Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor alpha antagonists. Arthritis Rheum 2007;56:1125-1133.
16. Smolen JS, Han C, Bala M, et al. Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: A detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study. Arthritis Rheum 2005;52:1020-1030.
17. Garlet GP, Cardoso CR, Campanelli AP, et al. The dual role of p55 tumour necrosis factor-alpha receptor in Actinobacillus actinomycetemcomitans- induced experimental periodontitis: Host protection and tissue destruction. Clin Exp Immunol 2007;147:128-138.